Liang, Y., Maeda, O., Kondo, C., Nishida, K., Ando, Y. (2025). Correction: Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma. PLoS ONE. https://doi.org/10.1371/journal.pone.0330099